Recent research indicates popular GLP-1 weight-loss medications may significantly impact sexual health. Studies suggest these drugs can increase testosterone, optimize hormone levels, and improve erectile function in men. Conversely, some research shows a potential decrease in sexual drive for women. A comprehensive survey found that about 52% of GLP-1 users reported an impact on their sex lives, with nearly equal numbers experiencing increases and decreases in sexual desire and function.
Experts note that outcomes vary based on individual patient characteristics and the severity of underlying conditions. Improved sexual function may stem from the medication's direct effects on blood flow and nerve function, or indirectly from psychological benefits like reduced depression and improved self-perception following weight loss. However, some patients experience reduced sexual desire due to potential modulation of brain reward pathways or common side effects like nausea and fatigue.